Brief: Cancer Genetics Says Director Resigned From Board

Interpace Biosciences

19/07/2019 22:49

July 19 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS SAYS ON JULY 8, BOARD GOT LETTER FROM JOHN
PAPPAJOHN AS PER WHICH HE RESIGNED AS DIRECTOR OF BOARD,
EFFECTIVE IMMEDIATELY - SEC FILING
    * CANCER GENETICS SAYS JOHN PAPPAJOHN, IN JULY 8 LETTER TO
CO,
SAYS HE WILL VOTE AGAINST CO'S ANNOUNCED AGREEMENT WITH
INTERFACE

Source text: [https://bit.ly/2Gk0EEK]
Further company coverage:  CGIX.O 

 (Reuters.Briefs@thomsonreuters.com)